Megan E. Garlapow, Ph.D | Executive Editor | Senior Medical Writer | Oncology, Hematology

As an experienced medical writer Garlapow has written about a wide range of topics including AML, breast cancer, pancreatic cancer, Hodgkin’s lymphoma, CLL, myelofibrosis, renal cell carcinoma, ovarian cancer, non-Hodgkin’s lymphoma, and more.

Garlapow developed scientific posters, abstracts, and slide decks for presentations at local and national conferences; written peer-reviewed manuscripts; developped market strategy reports; composed training modules; and written assessments for managed markets.

Before working as a medical writer, Garlapow worked in a biopsychology lab, examining social factors affecting breast cancer in rats and people and in a neurogenetics lab, examining the circadian factors affecting nicotine addiction in a mouse model.

She earned a Ph.D in genetics from North Carolina State University, using quantitative genetics approaches to examine the regulation of feeding. Her postdoctoral research at Arizona State University focused on environmental and genetic factors affecting body weight.


Last editorial review: October 21, 2016